Skip to content
AwardedSVKGoods€616,581

PALIVIZUMAB

Published
Published 7 August 2025
Deadline
Closed 8 September 2025

Overview

Liek je používaný na prevenciu závažného ochorenia dolných dýchacích ciest vyžadujúceho hospitalizáciu, ktoré je vyvolané respiračným syncyciálnym vírusom (RSV) u detí s vysokým rizikom ochorenia RSV. Uvedený liek sa podáva sezónne od októbra do apríla.

Key details

Country
SVK
Status
Awarded
Category
Goods
Estimated value
€616,581
Procedure
Open
SME suitable
Yes
Published
7 August 2025
Deadline
Closed
Classification (CPV)
Immunoglobulins

Award outcome

Awarded value
€598,605
Award date
30 September 2025
Contract period
— → 20 September 2027
Winner
  • MED - ART, spol. s r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    3 October 2025

  2. Contract Notice

    7 August 2025

Contracting authority

  • Detská fakultná nemocnica Košice

    Procuring entity

    Košice - mestská časť Západ, SVK

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: PALIVIZUMAB — won by MED - ART, spol. s r.o. — Skim